Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for Boards of Appeal
Non-reproducible prior art post-G 1/23: Novelty versus inventive step (T 1044/23) Non-reproducible prior art post-G 1/23: Novelty versus inventive step (T 1044/23) Reviewed by Dr Rose Hughes on Tuesday, November 18, 2025 Rating: 5
Never Too Late: If you missed the IPKat last week! Never Too Late: If you missed the IPKat last week! Reviewed by Asude Sena Moya on Wednesday, May 14, 2025 Rating: 5
Commercial success is a nothing-burger for the EPO in Wegovy patent inventive step analysis (T 1701/22, Obesity treatment with semaglutide) Commercial success is a nothing-burger for the EPO in Wegovy patent inventive step analysis (T 1701/22, Obesity treatment with semaglutide) Reviewed by Dr Rose Hughes on Thursday, May 08, 2025 Rating: 5
[GuestPost] G1/24: Tuning in! A take on the state of proceedings before oral proceedings [GuestPost] G1/24: Tuning in! A take on the state of proceedings before oral proceedings Reviewed by Dr Rose Hughes on Friday, March 28, 2025 Rating: 5
G 2/21 applied to software inventions (T 0687/22) G 2/21 applied to software inventions (T 0687/22) Reviewed by Dr Rose Hughes on Wednesday, March 26, 2025 Rating: 5
EBA's preliminary opinion in G1/24: "the description and the figures can be referred to in the course of claim interpretation" EBA's preliminary opinion in G1/24: "the description and the figures can be referred to in the course of claim interpretation" Reviewed by Dr Rose Hughes on Wednesday, February 12, 2025 Rating: 5
A new mode of administration is a new specific medical use (but not necessarily inventive) (T 0295/22) A new mode of administration is a new specific medical use (but not necessarily inventive) (T 0295/22) Reviewed by Dr Rose Hughes on Friday, February 07, 2025 Rating: 5
No delay following an intervention to an accelerated EPO appeal during parallel UPC proceedings (T 1841/23) No delay following an intervention to an accelerated EPO appeal during parallel UPC proceedings (T 1841/23) Reviewed by Dr Rose Hughes on Friday, January 31, 2025 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.